查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585814

乳房切片市場：按產品類型、指南、應用分類 - 2025-2030 年全球預測

Breast Biopsy Market by Product (Assay Kits, Biopsy Needles, Biopsy Tables), Type (Liquid Breast Biopsy, Needle Breast Biopsy, Open Surgical Breast Biopsy), Guidance, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年乳房切片市場價值為10億美元，預計2024年將達到10.9億美元，複合年成長率為9.26%，預計2030年將達到18.7億美元。

乳房切片市場的範圍包括從乳房中取出組織或液體以確定癌細胞是否存在的診斷程序，這對於早期檢測和治療計劃至關重要。它廣泛用於乳房X光攝影異常或可觸及腫塊的患者。典型的最終用戶包括醫院、診斷中心和門診手術中心。乳癌發病率的上升、早期診斷意識的提高以及對微創手術的需求不斷成長正在推動這一需求。影響市場成長的因素包括切片檢查儀器的技術進步，例如真空輔助和影像引導方法，這些方法提高了準確性並減少了手術的不適感。乳癌發生率的增加和政府促進早期診斷的措施進一步推動了市場擴張。目前的商機存在於醫療保健基礎設施正在改善的新興市場，為市場滲透提供了肥沃的土壤。公司可以利用人工智慧輔助影像分析和更適合患者的切片檢查通訊協定等創新來提高準確性和患者體驗。挑戰包括高昂的手術成本、患者因手術焦慮而不願，以及不一致的切片檢查結果導致假陽性和假陰性。克服監管障礙是一項額外的挑戰，因為任何新技術都必須遵守嚴格的安全性和有效性標準。為了實現永續成長，公司應專注於開發具有成本效益的解決方案並透過技術進步來提高程序精度。對侵入性較小的技術、改進的成像方式以及將人工智慧整合到預測診斷中的研究可以提供競爭優勢。此外，根據個人基因圖譜量身定做的個人化乳癌診斷工具是未來創新的一個有前途的領域。市場競爭溫和，主要企業不斷投資研發以獲得競爭優勢。促進與醫療保健提供者合作並投資於專業和患者教育的公司可能會佔據重要的市場佔有率並推動未來的市場動態。

主要市場統計
基準年[2023] 10億美元
預測年份 [2024] 10.9億美元
預測年份 [2030] 18.7億美元
複合年成長率（%） 9.26%

市場動態：快速發展的乳房切片市場的關鍵市場洞察

供需的動態交互作用正在改變乳房切片市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球乳癌發生率上升
    • 政府提高乳癌意識和治療的舉措
    • 改變早期乳癌檢測和篩檢的偏好
  • 市場限制因素
    • 檢驗高成本且耗時
  • 市場機會
    • 液態切片的出現和有前景的臨床試驗
    • 增加對乳癌治療研究和開發的投資和資助
  • 市場挑戰
    • 切片穿刺針感染的可能性

波特的五力：駕馭乳房切片市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解乳房切片市場的外部影響

外部宏觀環境因素在塑造乳房切片市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解乳房切片市場的競爭格局

乳房切片市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣乳房切片市場供應商的績效評估

FPNV定位矩陣是評估乳房切片市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了乳房切片市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對乳房切片市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球乳癌發生率正在上升
      • 政府提高乳癌意識和治療的舉措
      • 改變早期乳癌檢測和篩檢的偏好
    • 抑制因素
      • 一個昂貴且耗時的過程
    • 機會
      • 液態生物檢體的出現和有前景的臨床試驗
      • 增加對乳癌治療研究和開發的投資和資助
    • 任務
      • 與切片穿刺針相關的感染的可能性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章乳房切片市場：依產品

  • 檢測試劑套件
  • 切片穿刺針
  • 切片檢查台
  • 引導系統
  • 液態生物檢體儀器
  • 定位線

第7章乳房切片市場：依類型

  • 乳房切片
    • 循環性腫瘤細胞
    • 循環腫瘤DNA
  • 乳房切片
    • 空心針活體組織切片
    • 細針抽吸細胞學檢查
    • 抽吸輔助切片檢查
  • 開放性手術乳房切片
    • 切除
    • 切口

第8章乳房切片市場：依指導

  • 影像引導切片檢查
    • 乳房X光攝影引導切片檢查定位活體組織切片
    • MRI導引切片檢查
    • 超音波切片檢查
  • 液態生物檢體
    • 基於微陣列的切片檢查
    • 基於NGS的切片檢查
    • 基於PCR的切片檢查

第9章乳房切片市場：依應用分類

  • 早期癌症篩檢
  • 復發監測
  • 治療方法選擇
  • 治療監測

第10章美洲乳房切片市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太乳房切片市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的乳房切片市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Quest Diagnostics 收購 Haystack Oncology，將敏感液態生物檢體技術添加到其腫瘤產品組合中，以改善個人化癌症治療
    • Guardant Health 獲得 FDA核准Guardant360 CDx 作為美納里尼集團 ORSERDU 的伴同性診斷，用於治療 ESR1 突變的 ER+、HER2-進行性或轉移性乳癌患者
    • TransMed7 LLC 宣布 SpeedBird乳房切片設備首次臨床使用並進行商業性推廣
  • 戰略分析和建議

公司名單

  • Argon Medical
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc
  • Biocept, Inc.
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fluxion Biosciences Inc.
  • FUJIFILM Corporation
  • GE HealthCare
  • Guardant Health
  • Halma plc
  • Hologic, Inc.
  • Illumina, Inc.
  • INRAD, Inc.
  • Iskus Health Ltd.
  • Johnson & Johnson Services, Inc.
  • Leica Biosystems Nussloch GmbH
  • Medtronic PLC
  • Merit Medical Systems
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TransMed7, LLC
  • Trivitron Healthcare
Product Code: MRR-4F4C36263235

The Breast Biopsy Market was valued at USD 1.00 billion in 2023, expected to reach USD 1.09 billion in 2024, and is projected to grow at a CAGR of 9.26%, to USD 1.87 billion by 2030.

The scope of the breast biopsy market encompasses diagnostic procedures to extract tissue or fluid from the breast to determine the presence of cancerous cells, vital for early detection and treatment planning. It widely applies to patients with abnormal mammograms or palpable lumps. The key end-users include hospitals, diagnostic centers, and ambulatory surgical centers. The necessity is driven by rising breast cancer incidences, growing awareness regarding early diagnosis, and increased demand for less invasive procedures. Factors influencing market growth include technological advancements in biopsy instruments such as vacuum-assisted and image-guided methods, which enhance accuracy and reduce procedural discomfort. The increasing incidence of breast cancer and government initiatives promoting early diagnosis further bolster market expansion. Current opportunities lie in emerging markets with improving healthcare infrastructure, offering a fertile ground for market penetration. Businesses could leverage innovations such as AI-assisted image analysis and more patient-friendly biopsy protocols to enhance accuracy and patient experience. Challenges include high procedural costs, patient reluctance due to surgical anxiety, and discrepancies in biopsy results leading to false positives or negatives. Navigating regulatory hurdles poses an additional challenge, as any new technology must comply with stringent safety and efficacy standards. For sustainable growth, firms should focus on developing cost-effective solutions and enhancing procedural accuracy through technological advancements. Research into less invasive techniques, improved imaging modalities, and integrating AI for predictive diagnostics could provide competitive advantages. Moreover, personalized breast cancer diagnosis tools tailored to individual genetic profiles represent a promising area for future innovation. The market is moderately competitive, with key players continuously investing in research and development to gain a competitive edge. Companies that foster collaborations with healthcare providers and invest in educating professionals and patients are likely to capture significant market share and drive future market dynamics.

KEY MARKET STATISTICS
Base Year [2023] USD 1.00 billion
Estimated Year [2024] USD 1.09 billion
Forecast Year [2030] USD 1.87 billion
CAGR (%) 9.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Biopsy Market

The Breast Biopsy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of breast cancer worldwide
    • Government initiative for awareness and treatment of breast cancer
    • Shifting preferences for early detection and screening for breast cancer
  • Market Restraints
    • High-cost and time consuming procedure
  • Market Opportunities
    • Emergence of liquid biopsy and promising clinical trials
    • Increasing investments and funding for R&D of breast cancer treatment
  • Market Challenges
    • Possibilities of infection associated with biopsy needles

Porter's Five Forces: A Strategic Tool for Navigating the Breast Biopsy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Biopsy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Biopsy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Biopsy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Biopsy Market

A detailed market share analysis in the Breast Biopsy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Biopsy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Biopsy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Biopsy Market

A strategic analysis of the Breast Biopsy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Biopsy Market, highlighting leading vendors and their innovative profiles. These include Argon Medical, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, Biocept, Inc., Cook Group Incorporated, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd., Fluxion Biosciences Inc., FUJIFILM Corporation, GE HealthCare, Guardant Health, Halma plc, Hologic, Inc., Illumina, Inc., INRAD, Inc., Iskus Health Ltd., Johnson & Johnson Services, Inc., Leica Biosystems Nussloch GmbH, Medtronic PLC, Merit Medical Systems, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., TransMed7, LLC, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Assay Kits, Biopsy Needles, Biopsy Tables, Guidance Systems, Liquid Biopsy Instruments, and Localization Wires.
  • Based on Type, market is studied across Liquid Breast Biopsy, Needle Breast Biopsy, and Open Surgical Breast Biopsy. The Liquid Breast Biopsy is further studied across Circulating Tumor Cells and Circulating Tumor DNA. The Needle Breast Biopsy is further studied across Core Needle Biopsy, Fine Needle Aspiration Biopsy, and Vacuum-Assisted Biopsy. The Open Surgical Breast Biopsy is further studied across Excisional and Incisional.
  • Based on Guidance, market is studied across Image-Guided Biopsy and Liquid Biopsy. The Image-Guided Biopsy is further studied across Mammography-Guided Stereotactic Biopsy, MRI Guided Biopsy, and Ultrasound-Guided Biopsy. The Liquid Biopsy is further studied across Microarray-Based Biopsy, NGS-Based Biopsy, and PCR-Based Biopsy.
  • Based on Application, market is studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of breast cancer worldwide
      • 5.1.1.2. Government initiative for awareness and treatment of breast cancer
      • 5.1.1.3. Shifting preferences for early detection and screening for breast cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost and time consuming procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of liquid biopsy and promising clinical trials
      • 5.1.3.2. Increasing investments and funding for R&D of breast cancer treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Possibilities of infection associated with biopsy needles
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Breast Biopsy Market, by Product

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Biopsy Needles
  • 6.4. Biopsy Tables
  • 6.5. Guidance Systems
  • 6.6. Liquid Biopsy Instruments
  • 6.7. Localization Wires

7. Breast Biopsy Market, by Type

  • 7.1. Introduction
  • 7.2. Liquid Breast Biopsy
    • 7.2.1. Circulating Tumor Cells
    • 7.2.2. Circulating Tumor DNA
  • 7.3. Needle Breast Biopsy
    • 7.3.1. Core Needle Biopsy
    • 7.3.2. Fine Needle Aspiration Biopsy
    • 7.3.3. Vacuum-Assisted Biopsy
  • 7.4. Open Surgical Breast Biopsy
    • 7.4.1. Excisional
    • 7.4.2. Incisional

8. Breast Biopsy Market, by Guidance

  • 8.1. Introduction
  • 8.2. Image-Guided Biopsy
    • 8.2.1. Mammography-Guided Stereotactic Biopsy
    • 8.2.2. MRI Guided Biopsy
    • 8.2.3. Ultrasound-Guided Biopsy
  • 8.3. Liquid Biopsy
    • 8.3.1. Microarray-Based Biopsy
    • 8.3.2. NGS-Based Biopsy
    • 8.3.3. PCR-Based Biopsy

9. Breast Biopsy Market, by Application

  • 9.1. Introduction
  • 9.2. Early Cancer Screening
  • 9.3. Recurrence Monitoring
  • 9.4. Therapy Selection
  • 9.5. Treatment Monitoring

10. Americas Breast Biopsy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Breast Biopsy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Breast Biopsy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
    • 13.3.2. Guardant Health Receives FDA Approval for Guardant360 CDx as Companion Diagnostic for Menarini Group's ORSERDU for the Treatment of Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
    • 13.3.3. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Argon Medical
  • 2. Becton, Dickinson, and Company
  • 3. Bio-Rad Laboratories, Inc
  • 4. Biocept, Inc.
  • 5. Cook Group Incorporated
  • 6. CooperSurgical, Inc.
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Fluxion Biosciences Inc.
  • 9. FUJIFILM Corporation
  • 10. GE HealthCare
  • 11. Guardant Health
  • 12. Halma plc
  • 13. Hologic, Inc.
  • 14. Illumina, Inc.
  • 15. INRAD, Inc.
  • 16. Iskus Health Ltd.
  • 17. Johnson & Johnson Services, Inc.
  • 18. Leica Biosystems Nussloch GmbH
  • 19. Medtronic PLC
  • 20. Merit Medical Systems
  • 21. Siemens Healthineers
  • 22. Sysmex Corporation
  • 23. Thermo Fisher Scientific Inc.
  • 24. TransMed7, LLC
  • 25. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. BREAST BIOPSY MARKET RESEARCH PROCESS
  • FIGURE 2. BREAST BIOPSY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BREAST BIOPSY MARKET DYNAMICS
  • TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY MICROARRAY-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY NGS-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY PCR-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 345. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 346. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 352. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 354. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 355. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 361. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID